No Data
No Data
Express News | NYSE Halt Bio-Rad Labs B Add Info Lst $225.290000
RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Cuts Target Price to $409
Express News | Bio Rad Laboratories Inc : RBC Cuts Target Price to $409 From $430
Further Weakness as Bio-Rad Laboratories (NYSE:BIO) Drops 5.0% This Week, Taking Three-year Losses to 61%
RBC Capital Sticks to Its Buy Rating for Bio-Rad Laboratories (BIO)
Should You Investigate Bio-Rad Laboratories, Inc. (NYSE:BIO) At US$244?
affable Blobfish_403 : The intense struggle between political power and market power in the election, the outcome is uncertain, today's debate is a major highlight.
章允量 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
104476495 : hi